YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Twist Bioscience Takes in Funding Round for DNA Synthesizer


May 28, 2014 | Twist Bioscience yesterday announced a $26 million Series B funding round, as well as a $5 million DARPA contract, to continue development of a high-throughput DNA synthesis device. The Twist machine performs synthesis on a silicon semiconductor chip with thousands of microwells, which the developers expect to increase the speed with which new DNA can be manufactured while controlling errors. The new funding will be put toward hiring dozens of employees in the San Francisco area and a proposed service launch in 2015. Xconomy
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.